Zydus Cadila Gets USFDA Nod

The tablets will be manufactured at the group's manufacturing facility at SEZ, Ahmedabad, Zydus Cadila said.

The approval is for single-dose vials of Cisatracurium Besylate Injection USP with strengths of 10 mg/5 ml and 200 mg/20 ml

The company remains committed to patient safety and meeting the expectations of regulatory compliances, the Gujarat-based firm said.

Zydus Cadila said the newly-approved product will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad

The group has also received the final approval for its Rosuvastatin tablets in the strengths of 5 mg, 10 mg, 20 mg, and 40 mg

Zydus Cadila said the drug will be manufactured at the group's Topical manufacturing facility at Ahmedabad

The approved drug will be produced at the group's formulation manufacturing facility at Moriya, Ahmedabad

Drug will be manufactured at firm's Ahmedabad SEZ unit, group now has 202 approvals, has so far filed over 330 ANDAs since commencement of filing process

The drug is also used to for preventing stomach bleeding in very ill patents

The drug is indicated for the treatment of erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia